Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data validation
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Retinoblastoma treatment industry 3600 synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Disease type trends
2.1.4 Disease stage trends
2.1.5 Treatment trends
2.1.6 End-user trends
Chapter 3 Retinoblastoma Treatment Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of retinoblastoma
3.2.1.2 Early diagnosis and treatment of retinoblastoma
3.2.2 Industry pitfalls & challenges
3.2.2.1 High treatment cost
3.2.2.2 Side effects associated with retinoblastoma treatment
3.3 Growth potential analysis
3.3.1 By disease type
3.3.2 By disease stage
3.3.3 By treatment type
3.3.4 By end-user
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic dashboard, 2023
Chapter 5 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Type, 2018-2032 (USD Million)
5.1 Key trends, by disease type
5.2 Non-hereditary retinoblastoma
5.3 Hereditary retinoblastoma
Chapter 6 Retinoblastoma Treatment Market Estimates and Forecast, By Disease Stage, 2018-2032 (USD Million)
6.1 Key trends, by disease stage
6.2 Intraocular retinoblastoma
6.3 Extraocular retinoblastoma
Chapter 7 Retinoblastoma Treatment Market Estimates and Forecast, By Treatment Type, 2018-2032 (USD Million)
7.1 Key trends, by treatment type
7.2 Chemotherapy
7.3 Radiation therapy
7.4 Surgery
7.5 Laser therapy
7.6 Cryotherapy
Chapter 8 Retinoblastoma Treatment Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)
8.1 Key trends, by end-user
8.2 Hospitals
8.3 Cancer treatment centers
8.4 Specialty eye clinics
Chapter 9 Retinoblastoma Treatment Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 Rest of Middle East & Africa
Chapter 10 Company Profiles
10.1 Baxter International Inc.
10.2 Bristol-Myers Squibb Company
10.3 GlaxoSmithKline plc
10.4 Johnson & Johnson
10.5 Merck & Co., Inc.
10.6 Novartis AG
10.7 Pfizer Inc.
10.8 Teva Pharmaceutical Industries Ltd.
10.9 Cadila Pharmaceuticals
10.10 Cellceutix Corporation
